Centaurus Financial »

Vaneck Vectors Pharmaceutical etf shares owned by Centaurus Financial

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Centaurus Financial from 13F filings

Historical chart of Centaurus Financial investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Centaurus Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Centaurus Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $137k 1.4k 95.14
2024-06-30 $134k 1.5k 91.78
2024-03-31 $126k 1.4k 90.65
2018-06-30 $1.0k 16 62.50

More positions owned by Centaurus Financial

Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Select Sector Spdr Tr Technology (XLK)
Floor & Decor Hldgs Cl A (FND)
Peakstone Realty Trust Common Shares (PKST)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Meta Platforms Cl A (META)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)

View all positions for Centaurus Financial

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
J.Safra Asset Management
Mivtachim The Workers Social Insurance Fund
Miller Investment Management
Thrivent Financial for Lutherans
Adamsbrown Wealth Consultants
Two Sigma Investments
Prime Capital Investment Advisors
Bank of America Corporation
Morgan Stanley
Susquehanna International
Bnp Paribas Arbitrage, Snc
Independent Advisor Alliance

View all funds holding Vaneck Vectors Pharmaceutical etf